1 / 4

Nuclear Power In Finland Market Outlook To 2025 Research Report

“The Report Nuclear Power In Finland Market Outlook To 2025 Update 2015 - Capacity Generation Power Plants Investment Trends Regulations And Company Profiles provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz”

rakeshmrrbiz
Télécharger la présentation

Nuclear Power In Finland Market Outlook To 2025 Research Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Partnerships Licensing Investments And M&A Deals And Trends For May 2015 Available at MarketResearchReports.Biz “The Report Partnerships Licensing Investments And M&A Deals And Trends For May 2015 In Pharmaceuticals provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz” Summary GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends for May 2015 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in May 2015. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry. Data presented in this report is derived from GlobalDatas proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research. View Full Report at http://www.marketresearchreports.biz/analysis/308861 Scope - Analysis of the market trends for the pharmaceutical industry in the global arena. - Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments. - Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry. - Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As. - Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry. - Analysis of partnership and licensing deals based on clinical stage of development of products. - Summary of the pharmaceutical deals globally in the six months. - Information on the top deals happened in the pharmaceutical industry.

  2. - Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. - League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs. Download sample Copy of This Report at http://www.marketresearchreports.biz/sample/sample/308861 Reasons to buy - Enhance your decision making capability in a more rapid and time sensitive manner. - Find out the major deal performing segments for investments in your industry. - Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets. - Identify companies that are aggressively looking to raise capital in the market - Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry. - Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies. - Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening. - Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry. - Identify growth segments and opportunities in each region within the industry. - Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry. Table of Contents 1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 5 1.2 List of Figures 8 2 Pharmaceuticals & Healthcare, Global, Deal Summary 12 2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, May 2015 12 2.2 Pharmaceuticals & Healthcare, Global, Major Deals, May 2015 14 2.2.1 AbbVie Raises USD16.7 Billion in Public Offering Notes 14 2.2.2 Danaher to Acquire Pall for USD13.8 Billion 14 2.2.3 Alexion Pharma to Acquire Synageva BioPharma for USD8.4 Billion 17 2.2.4 Endo International to Acquire Par Pharma from TPG Capital for USD8.05 Billion 19 2.2.5 Eli Lilly Prices Public Offering of Bonds for USD2.3 Billion 19 2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, May 2015 20 2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, May 2015 21 3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 22 3.1 Pharmaceuticals & Healthcare, Global, M&A, May 2015 22 3.1.1 Top M&A Deals in May 2015 23 3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, December 2014 - May 2015 24 3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, May 2015 26 3.2.1 Top Equity Offering Deals in May 2015 27 3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, December 2014 - May 2015 28 3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, May 2015 30

  3. 3.3.1 Top PE/VC Deals in May 2015 31 3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, May 2015 32 3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, May 2015 34 3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, December 2014-May 2015 36 3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, December 2014-May 2015 37 4 Pharmaceuticals & Healthcare, Global, Partnership Deals, May 2015 38 4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, May 2015 38 4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, December 2014 - May 2015 40 4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), May 2015 42 4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, May 2015 43 4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), December 2014 - May 2015 44 4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, December 2014 - May 2015 46 4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), December 2014 - May 2015 47 4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), December 2014 - May 2015 49 5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, May 2015 51 5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, May 2015 51 5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), May 2015 53 5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), December 2014 - May 2015 55 5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), December 2014 - May 2015 57 5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), December 2014 - May 2015 59 To View The Top Article Of Comapny: http://www.marketresearchreports.biz/articles About Us MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. Contact Us Mr. Nachiket Office: State Tower 90 Sate Street, Suite 700 Albany, NY 12207 United States

  4. Tel: +1-518-621-2074 Website: http://www.marketresearchreports.biz/ E: sales@marketresearchreports.biz

More Related